Werewolf Therapeutics, Inc. (the“Company” or“Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, today announced the dosing ...

Ms. Eastland is an independent director of Dynavax Technologies Corporation, Lantheus, and Seismic Therapeutic. Ms. Eastland received ... and has demonstrated anti-tumor activity as a single agent ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes the announcement by the United States (U.S.) Centers for Medicare & Medicaid Services (CMS) that it will pay separately for ...

Telix is also reviewing the potential use of Pixclara as a “companion” diagnostic agent for TLX101-Tx, the investigational neuro-oncology drug currently in development, which targets the same amino ...

The partnership with Telix, which covers North America and the European Union (EU, excluding France and French speaking Belgium), launches in the United States (U.S.) with Illuccix, with the aim to ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle ...

Smith Faculty of Agriculture, Food & Environment, showcases a novel therapeutic strategy to combat infections ... Addressing ...

In a recent article, researchers synthesized and characterized amino acid-functionalized magnetite nanoparticles, exploring ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...